How can community pharmacy teams improve their inclusive practice? |Chemist+Drugist :: C+D

How can we improve the health and well-being of our diverse local communities?

This is the question we aim to answer in our work on the national Inclusive Pharmacy Practice (IPP) program – a group of 15 partner organizations who are committed to improving our practice and effecting positive change. Our goal is to enable pharmacy professionals to engage more effectively with their local communities.

Inclusive pharmacy practice is such an important area – it’s about addressing inequities for those with the worst health outcomes. These people include ethnic minority communities, people with disabilities, homeless people, people living in deprived neighborhoods and the elderly.

And community pharmacists and their teams are uniquely positioned to do this, especially because of the first-hand knowledge you all have of your local communities and greater awareness of their health needs.

Engage professionals and showcase best practices

In addition to the IPP program, through the National Advisory Board and its leadership, we have now launched our “National Practice and Engagement Improvement Group”, which includes high-level representatives from partner organizations.

The purpose of this group is to identify and share examples within their own organizations to reach out to communities and share this content in a bi-annual newsletter focused on key topics of inclusive pharmacy practice. This aims to support pharmacy professionals working in all environments. The National Advisory Board has chosen Cardiovascular Disease (CVD) as the first topic to cover and will be the theme for the first newsletter.

Cardiovascular disease is strongly associated with health inequalities – people living in the most deprived areas of England are almost four times more likely to die prematurely from the disease than those in less deprived areas. It is also more likely to affect someone who is male, older, has a serious mental illness, or is of South Asian or Afro-Caribbean descent. This work reflects the goals of Core20PLUS5, a national NHS England and NHS Improvement (NHSE&I) approach to support the reduction of health inequalities. It identifies five clinical areas to focus on, including chronic respiratory disease and hypertension case finding.

Day Lewis and Green Light will present examples in a webinar

To help further support the work of community pharmacists and their teams in providing a more personalized service within their local community, NHSE&I is running a webinar in partnership with the Royal Pharmaceutical Society and the Association of Pharmacy Technicians UK on Thursday 19 May.

The event will share best practices in population health management and how they can reduce health inequities, looking at useful tools such as At your fingertips to support the management of the health needs of the local population. It will also feature excellent community pharmacy case studies from Day Lewis and Green Light Pharmacy.

This is one of a series of webinars exploring issues related to inclusive pharmacy practice. We know that community pharmacy professionals have a wealth of experience in this area that they can share, and we want to provide a platform to do so. We want to hear your ideas about what works well and encourage you to get involved in our plans to showcase and promote learning.

Ideally, we would like all of our community pharmacists and their teams to be able to regularly access and easily use the appropriate tools and resources around population health, and embrace a more inclusive practice culture that together can help reduce health inequalities from meaningful and effective way. within their local communities.

Community Pharmacy is already doing amazing work in this area, but the first webinar on May 19 will provide resources that could help make this work even better.

I look forward to seeing you there.

Sign up for the webinar on population health management here.

Keep up to date with this work and look for ways to get involved by following me on Twitter: @drmahendrapatel

Professor Mahendra Patel is Professional Advisor to the Chief Pharmaceutical Officer of England and Co-Chair of the National Practice Improvement and Engagement Council

Comments are closed.